BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

DTx Leader Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Cancer

International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), today announces an integrated digital therape...

June 20, 2022 | News

Nonagen Bioscience announces CE mark for Oncuria® bladder cancer diagnostic

Oncuria is the first-of-its-kind multiplex urine test for the quantitative detection of 10 biomarkers in urine that are associated with the presence of...

June 17, 2022 | News

Atik Cameras launches new CMOS camera optimised for long exposure imaging

Atik Cameras, a specialist designer and manufacturer of advanced scientific cameras, has launched ChemiMOS, the first in a series of high-resolution comple...

June 15, 2022 | News

Telix and RefleXion Expand Partnership for Prostate Cancer Treatment

BgRT is the first and only cancer treatment designed to integrate PET technology as part of external-beam radiotherapy delivery. It uses PET tracers a...

June 13, 2022 | News

EpiVax Poxvirus Vaccine Candidate Predicted to be Effective Against Monkeypox

The development of this vaccine was funded by the National Institutes of Health (SBIR grant #R43AI058376). The company is looking for a strategic part...

June 13, 2022 | News

Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong

Test sensitivity of 96% in colorectal cancer and 64% in advanced adenoma detection in clinical studies- ColoClear is the only cancer screening test ap...

June 09, 2022 | News

Everest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02

Everest Medicines (HKEX 1952.HK) announces today that its licensing partner, Gilead Sciences, Inc. (Nasdaq: GILD), reported positive results from the prima...

June 06, 2022 | News

Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury

"The successful completion of the proposed study is intended to provide key information pertaining to AB126™ dosage, and therapeutic effects on T...

June 01, 2022 | News

World's first contactless blood pressure and vital sign measurement comes to Singapore

NuraLogix are the pioneers of the world's first contactless blood pressure and vital sign measurement. Their technology uses their patented Transdermal Op...

June 01, 2022 | News

HistoSonics Announces Agreement with GE Healthcare

HistoSonics Inc., developer of a completely non-invasive platform using the science of histotripsy, today announced an agreement formalizing ongoing effort...

May 24, 2022 | News

FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder

"As researchers and clinicians have gained knowledge about eosinophilic esophagitis in recent years, more cases of the disorder have been recognized and di...

May 23, 2022 | News

New therapeutic option to reduce risk of cardiovascular deaths and repeated hospitalizations among adult heart failure patients approved in Singapore

Over the course of the VICTORIA study, there was a 4.2% reduction in annualized absolute risk with VERQUVO™ (vericiguat) compared with pl...

May 18, 2022 | News

Varian partners with Icon Group to advance patient-centric solutions

Varian, a Siemens Healthineers company (Varian), today announced a five-year research and professional services agreement with Icon Group (Icon). Through t...

April 29, 2022 | News

South Korea to advance treatments for rare pediatric diseases in Asian countries

As announced earlier (https://adgepharm.com/news/mar-22-2022/), Adge has secured a global license to RO269228, a clinical stage oral small molecule origina...

April 26, 2022 | News

Stay Connected